{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:30:07Z","timestamp":1786509007803,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Although many children infected with severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) or seasonal influenza virus experience a mild course of disease, both infections can lead to hospitalization and, in a subset of children, severe disease requiring intensive care unit (ICU) admission for respiratory or cardiac support. To compare the epidemiology, risk factors, clinical presentation and outcomes of children hospitalized with COVID-19 or seasonal influenza, and to identify factors associated with severe disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data were collected prospectively within a nationwide surveillance system across Swiss hospitals between December 2018 and November 2023. A comparative analysis was performed among children and adolescents (&lt;18 years) hospitalized with laboratory-confirmed SARS-CoV-2 or seasonal influenza infection. SARS-CoV-2 data were analyzed according to four time periods defined by the predominantly circulating virus variant: wild type (T1), Alpha (T2), Delta (T3) and Omicron (T4). Influenza data were analyzed across two periods: \u201cpre-COVID\u201d (December 2018 to April 30, 2020) and \u201cduring COVID\u201d (May 1, 2020, to November 30, 2023).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of 4662 included children, 3132 (67.2%) were hospitalized with SARS-CoV-2 infection and 1530 (32.8%) with influenza. Age distribution differed by virus and period (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001): infants accounted for one-third to almost half of SARS-CoV-2 admissions (32.2%\u201346.7%), with adolescents also contributing notably during T1 (22.7%), whereas toddlers and school-aged children were more frequently hospitalized with influenza infection. Fever, cough and rhinitis were the most common symptoms for both viruses. Among periods with symptom data available, fever was less frequent during SARS-CoV-2 T4 (47.3%) than during earlier SARS-CoV-2 waves (62.8% in T1, 55.7% in T2 and 64.9% in T3) and was also less frequent among children with influenza during the COVID period (26.0%). Anosmia was recorded only among children with SARS-CoV-2 infection (most often during T1: 1.2%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Proportions of severe symptoms were also similar, except respiratory distress being more common during T4 (12.6%) and with influenza (18.1%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02). Acute respiratory distress syndrome was recorded only among children hospitalized with influenza and not among those hospitalized with SARS-CoV-2. ICU admissions were highest during influenza seasons (pre-COVID 10.5% and during COVID 11.8%) compared with 5.0% to 10.3% with SARS-CoV-2 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). Complications were more frequent in children with seasonal influenza (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), most commonly lobar pneumonia, which occurred in up to 20% of children with influenza. During T3, deconditioning syndrome was more frequently reported (5.6%) than in other periods. Antibiotic use was higher in children with influenza (40.7% vs. 14.4%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Factors independently associated with severe disease were neurological, cardiovascular and other underlying conditions in children with COVID-19, and neurological and respiratory conditions in children with influenza.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Among hospitalized children with laboratory-confirmed infection, influenza was associated with more frequent ICU admission, complications, antibiotic use and respiratory support than SARS-CoV-2. Although underlying conditions were associated with an increased risk for severe disease, most children had no preexisting underlying conditions. These findings support consideration of broader pediatric influenza vaccination strategies beyond traditional high-risk groups and the need for ongoing surveillance to monitor evolving disease patterns and inform clinical and public health decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005350","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:00:18Z","timestamp":1786507218000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Epidemiology, Risk Factors, Clinical Presentation and Outcomes of COVID-19 and Seasonal Influenza Among Hospitalized Swiss Children: A Nationwide Prospective Surveillance Study"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2388-4318","authenticated-orcid":false,"given":"Petra","family":"Zimmermann","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland"},{"name":"Department of Paediatrics, Children\u2019s Hospital of Central Switzerland, Lucerne, Switzerland"},{"name":"Faculty of Science and Medicine, Department for Community Health, University of Fribourg, Fribourg, Switzerland"},{"name":"Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-7590","authenticated-orcid":false,"given":"Carlos","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Paediatric Research Centre, University Children\u2019s Hospital Basel, Basel Switzerland and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buettcher","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland"},{"name":"Department of Paediatrics, Children\u2019s Hospital of Central Switzerland, Lucerne, Switzerland"},{"name":"Paediatric Pharmacology and Pharmacometrics Research Center, University Children\u2019s Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-6778","authenticated-orcid":false,"given":"Ulrich","family":"Heininger","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Faculty of Medicine, University of Basel, Basel, Switzerland"},{"name":"Infectious Diseases and Vaccinology, University Children\u2019s Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3902-5489","authenticated-orcid":false,"given":"Julia A.","family":"Bielicki","sequence":"additional","affiliation":[{"name":"Paediatric Research Centre, University Children\u2019s Hospital Basel, Basel Switzerland and"},{"name":"Department of Clinical Research, Faculty of Medicine, University of Basel, Basel, Switzerland"},{"name":"Infectious Diseases and Vaccinology, University Children\u2019s Hospital Basel, Basel, Switzerland"},{"name":"Centre for Neonatal and Paediatric Infection, City St George\u2019s, University of London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the CH-SUR Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"R1-20260812","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/INF.0000000000002660","article-title":"Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children.","volume":"39","author":"Zimmermann","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R2-20260812","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2352-4642(20)30177-2","article-title":"COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.","volume":"4","author":"G\u00f6tzinger","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"R3-20260812","doi-asserted-by":"crossref","first-page":"e1012","DOI":"10.1093\/cid\/ciac734","article-title":"The spectrum of influenza in children.","volume":"76","author":"Hoy","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R4-20260812","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00431-021-04276-9","article-title":"Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study.","volume":"181","author":"Uka","year":"2022","journal-title":"Eur J Pediatr"},{"key":"R5-20260812","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1016\/S2214-109X(19)30545-5","article-title":"Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R6-20260812","doi-asserted-by":"crossref","first-page":"100433","DOI":"10.1016\/j.eclinm.2020.100433","article-title":"COVID-19 in 7780 pediatric patients: a systematic review.","volume":"24","author":"Hoang","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R7-20260812","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/INF.0000000000002700","article-title":"COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features.","volume":"39","author":"Zimmermann","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20260812","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/cid\/ciac296","article-title":"Epidemiology, clinical characteristics, and outcomes of influenza-associated hospitalizations in US children over 9 seasons following the 2009 H1N1 pandemic.","volume":"75","author":"Kamidani","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R9-20260812","first-page":"614","article-title":"Coronavirus disease 2019 versus influenza A in children: an observational control study in China.","volume":"33","author":"Zhao","year":"2020","journal-title":"Biomed Environ Sci"},{"key":"R10-20260812","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/INF.0000000000002705","article-title":"Comparison of the clinical features of SARS-CoV-2, other coronavirus and influenza infections in infants less than 1-year-old.","volume":"39","author":"Vanhems","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20260812","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/kjm2.12353","article-title":"Comparison of laboratory data between children with COVID-19 and influenza.","volume":"37","author":"Liu","year":"2021","journal-title":"Kaohsiung J Med Sci"},{"key":"R12-20260812","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijid.2020.06.026","article-title":"Comparison of hospitalized patients with pneumonia caused by COVID-19 and influenza A in children under 5 years.","volume":"98","author":"Li","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R13-20260812","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3345\/cep.2021.00066","article-title":"Comparison of clinical features and laboratory findings of coronavirus disease 2019 and influenza A and B infections in children: a single-center study.","volume":"64","author":"Siddiqui","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"R14-20260812","doi-asserted-by":"crossref","first-page":"e14466","DOI":"10.1111\/ijcp.14466","article-title":"Does Covid-19 in children have a milder course than Influenza?","volume":"75","author":"Yilmaz","year":"2021","journal-title":"Int J Clin Pract"},{"key":"R15-20260812","doi-asserted-by":"crossref","first-page":"e2020495","DOI":"10.1001\/jamanetworkopen.2020.20495","article-title":"Comparison of clinical features of COVID-19 vs seasonal influenza A and B in US children.","volume":"3","author":"Song","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R16-20260812","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12519-021-00432-1","article-title":"Distinctive clinical and laboratory features of COVID-19 and H1N1 influenza infections among hospitalized pediatric patients.","volume":"17","author":"Asseri","year":"2021","journal-title":"World J Pediatr"},{"key":"R17-20260812","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12879-021-06037-3","article-title":"Comparison of clinical features on admission between coronavirus disease 2019 and influenza A among children: a retrospective study in China.","volume":"21","author":"Liang","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R18-20260812","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12879-021-06068-w","article-title":"Comparative study of hospitalized children with acute respiratory distress syndrome caused by SARS-CoV-2 and influenza virus.","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R19-20260812","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1038\/s41598-021-85340-0","article-title":"Comparison of clinical severity and epidemiological spectrum between coronavirus disease 2019 and influenza in children.","volume":"11","author":"Pokorska-\u015apiewak","year":"2021","journal-title":"Sci Rep"},{"key":"R20-20260812","doi-asserted-by":"crossref","first-page":"e2273","DOI":"10.6061\/clinics\/2020\/e2273","article-title":"Differences among severe cases of Sars-CoV-2, influenza, and other respiratory viral infections in pediatric patients: symptoms, outcomes and preexisting comorbidities.","volume":"75","author":"Sousa","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"key":"R21-20260812","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1002\/jmv.27817","article-title":"Influenza is more severe than our newest enemy (COVID-19) in hospitalized children: experience from a tertiary center.","volume":"94","author":"Tasar","year":"2022","journal-title":"J Med Virol"},{"key":"R22-20260812","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/microorganisms13030517","article-title":"Epidemiology and clinical characteristics of laboratory-confirmed COVID-19 and influenza infections in children: a 2015-2024 study in Taiwan.","volume":"13","author":"Lee","year":"2025","journal-title":"Microorganisms"},{"key":"R23-20260812","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/apa.17061","article-title":"The changing clinical presentation of COVID-19 in children during the course of the pandemic.","volume":"113","author":"Wurm","year":"2024","journal-title":"Acta Paediatr"},{"key":"R24-20260812","first-page":"100405","article-title":"Severe COVID-19 outcomes in pediatrics: an observational cohort analysis comparing Alpha, Delta, and Omicron variants.","volume":"18","author":"Bahl","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"R25-20260812","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s15010-023-01996-y","article-title":"Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality.","volume":"51","author":"Jank","year":"2023","journal-title":"Infection"},{"key":"R26-20260812","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamapediatrics.2022.0945","article-title":"Incidence rates and clinical outcomes of SARS-CoV-2 infection with the omicron and delta variants in children younger than 5 years in the US.","volume":"176","author":"Wang","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R27-20260812","doi-asserted-by":"crossref","first-page":"146","DOI":"10.15585\/mmwr.mm7104e4","article-title":"Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods - United States, December 2020-January 2022.","volume":"71","author":"Iuliano","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R28-20260812","doi-asserted-by":"crossref","first-page":"1197156","DOI":"10.3389\/fped.2023.1197156","article-title":"Febrile seizure in children with COVID-19 during the Omicron wave.","volume":"11","author":"Xu","year":"2023","journal-title":"Front Pediatr"},{"key":"R29-20260812","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/apa.16276","article-title":"Convulsions in children with COVID-19 during the Omicron wave.","volume":"111","author":"Ludvigsson","year":"2022","journal-title":"Acta Paediatr"},{"key":"R30-20260812","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.jiac.2022.08.004","article-title":"Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period.","volume":"28","author":"Shoji","year":"2022","journal-title":"J Infect Chemother"},{"key":"R31-20260812","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S2352-4642(22)00027-X","article-title":"Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.","volume":"6","author":"Cloete","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"R32-20260812","doi-asserted-by":"crossref","first-page":"w20475","DOI":"10.4414\/smw.2021.20475","article-title":"Cohort profile: SARS-CoV-2\/COVID-19 hospitalised patients in Switzerland.","volume":"151","author":"Thiabaud","year":"2021","journal-title":"Swiss Med Wkly"},{"key":"R33-20260812","doi-asserted-by":"crossref","first-page":"w20547","DOI":"10.4414\/smw.2021.20547","article-title":"Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.","volume":"151","author":"Maximiano Sousa","year":"2021","journal-title":"Swiss Med Wkly"},{"key":"R34-20260812","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R35-20260812","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/INF.0000000000004332","article-title":"Clinical and laboratory biomarkers as predictors of severity in pediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2: data from a prospective nationwide surveillance study in Switzerland.","volume":"43","author":"Wurm","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R36-20260812","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2352-4642(23)00020-2","article-title":"Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.","volume":"7","author":"Welzel","year":"2023","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:00:23Z","timestamp":1786507223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005350","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}